⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients

Official Title: Multicenter Randomized Double-blind Phase III Clinical Trial Comparing Safety and Efficacy of BCD-022 (CJSC BIOCAD, Russia) Used With Paclitaxel to Herceptin® Used With Paclitaxel in the First-line Treatment of HER2+ Metastatic Breast Cancer Patients

Study ID: NCT01764022

Study Description

Brief Summary: BCD-022-02 is a double-blind randomized clinical trial comparing efficacy of BCD-022 (INN: trastuzumab) and paclitaxel to Herceptin and paclitaxel in HER2-positive metastatic breast cancer with pharmacokinetics substudy. The purpose of the study is to demonstrate the non-inferiority of efficacy and safety of BCD-022 compared to Herceptin. Also study includes pharmacokinetics assessment.

Detailed Description: The study is based on the hypothesis of equivalence of BCD-022 (trastuzumab by JSC BIOCAD, Russia) in combination with paclitaxel used as the therapy of inoperable or metastatic HER2(+) breast cancer in comparison with Herceptin® (F. Hoffmann-La Roche Ltd., Switzerland) in combination with paclitaxel. The objectives of the study is to evaluate efficacy, safety and pharmacokinetics of BCD-022 compared with reference trastuzumab by 1. overall response rate and other efficacy parameters; 2. incidence and severity of adverse events; 3. serum concentration after the first and multiple trastuzumab administration; 4. incidence and concentration of anti-trastuzumab antibodies.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Brest Region Clinical Oncology Dispensary, Brest, , Belarus

Gomel Region Clinical Oncology Dispensary, Gomel, , Belarus

Grodno Regional Hospital, Grodno, , Belarus

Vitebsk State Medical University of Order of Peoples' Friendship, Vitebsk, , Belarus

HCG Bangalore Institute of Oncology, Bangalore, , India

M.S.Ramaiah Memorial Hospital, Bangalore, , India

Narayana Hrudayalaya Hospitals, Bangalore, , India

State Health Institution of Moscow "Moscow City Oncology Hospital #62 of Moscow Board of Health", Stepanovskoye, Moscow Region, Russian Federation

Arkhangelsk District Clinical Oncology Dispensary, Arkhangelsk, , Russian Federation

Non-governmental Healthcare Institution "Railway Clinical hospital on the Chelyabinsk Station of JSC Russian Railways", Chelyabinsk, , Russian Federation

State-financed Health Institution "Chelyabinsk Region Clinical Oncology Dispansary", Chelyabinsk, , Russian Federation

State-financed Health Institution "Republican Clinical Oncology Hospital", Izhevsk, , Russian Federation

Institution of Russian Academy of Medical Sciences "Russian Cancer Research Center named after N.N. Blokhin", Moscow, , Russian Federation

Federal State Institution "Moscow Institute of Cancer Research named after P.A. Hertsen" Ministry of Health of Russian Federation, Moscow, , Russian Federation

Regional State Health Institution "Orlov Oncology Dispansary", Orel, , Russian Federation

State Health Institution "Region Oncology Dispansary", Penza, , Russian Federation

Perm Region Oncology Dispensary, Perm, , Russian Federation

Federal Government Budgetary Institution "Rostov Institute of Cancer Research" of Ministry of Health of Russian Federation, Rostov-on-Don, , Russian Federation

Saint Petersburg City Clinical Oncology Center, Saint Petersburg, , Russian Federation

State-financed Health Institution "Samara Region Clinical Oncology Dispansary", Samara, , Russian Federation

Oncology Dispensary 2, Sochi, , Russian Federation

Military Medical Academy named after S.M. Kirov, St.Petersburg, , Russian Federation

N.N.Petrov Oncology Research Center, St.Petersburg, , Russian Federation

Russian scientific center of radiology and surgery technologies, St.Petersburg, , Russian Federation

State-financed Health Institution "Stavropol Region Clinical Oncology Dispansary", Stavropol, , Russian Federation

Republican Clinical Oncology Dispensary of Ministry of Health republic Bashkortostan, Ufa, , Russian Federation

Volgograd District Oncology Dispensary №1, Volgograd, , Russian Federation

Donetsk City Oncology Dispensary, Donetsk, , Ukraine

Donetsk Regional Antitumor Center, Donetsk, , Ukraine

Kharkiv Regional Clinical Oncology Center, Kharkiv, , Ukraine

Kryvyi Rih Oncology Dispensary, Kryvyi Rih, , Ukraine

Lviv Regional State Cancer Diagnostics and Treatment Center, Lviv, , Ukraine

City Hospital №2, Makiivka, , Ukraine

Poltava Regional Clinical Oncology Dispensary, Poltava, , Ukraine

Zakarpatskyi Regional Clinical Oncology Center, Uzhhorod, , Ukraine

Vinnytsia Regional Clinical Oncology Dispensary, Vinnytsia, , Ukraine

Contact Details

Name: Roman Ivanov, MD, PhD

Affiliation: Vice-president, R&D

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: